| Case Page

 | Case Page |

Case Page

 

Anavex Life Sciences Corp

Case Summary

Anavex Life Sciences Corp Securities Litigation

Case Summary

Case Status:    DISMISSED    
On or around 03/29/2017 (Other)

Filing Date: December 30, 2015

According to the law firm press release, the Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Anavex had used a paid stock promoter to artificially inflate the Company’s share price; and (ii) as a result of the foregoing, Anavex’s public statements were materially false and misleading at all relevant times.

On April 5, 2016, the Court issued an Order appointing Lead Plaintiff and Lead Counsel. Lead Plaintiff filed an amended complaint on May 13.

On December 29, 2016, the Court issued an Order granting Defendants' Motion to Dismiss. Judgment in favor of Defendants was entered.

Company & Securities Information

Defendant: Anavex Life Sciences Corp

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: AVXL
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.

First Identified Complaint

Kevin Cortina, et al. v. Anavex Life Sciences Corp, et al.

COURT: S.D. New York
DOCKET #: 15-CV-10162
JUDGE: Hon. Jesse M. Furman
DATE FILED: 12/30/2015
CLASS PERIOD START: 05/17/2013
CLASS PERIOD END: 12/28/2015
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Pomerantz LLP (New York)
    600 Third Avenue, Pomerantz LLP (New York), NY 10016
    212.661.1100 212.661.8665 · info@pomerantzlaw.com/
First Identified Complaint (FIC) Filings:
No Document Title Filing Date
1 Complaint for Violation of the Federal Securities Laws 12/30/2015
2 Memorandum Opinion and Order 04/05/2016

Reference Complaint

Kevin Cortina, et al. v. Anavex Life Sciences Corp, et al.

COURT: S.D. New York
DOCKET #: 15-CV-10162
JUDGE: Hon. Jesse M. Furman
DATE FILED: 05/13/2016
CLASS PERIOD START: 05/17/2013
CLASS PERIOD END: 12/30/2015
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Levi & Korsinsky, LLP
    30 Broad Street, 15 1h Floor, Levi & Korsinsky, LLP, NY 10004
    212.363.7500 212.363-7171 ·
Reference Complaint (REF) Filings:
No Document Title Filing Date
1 Amended Complaint for Violation of the Federal Securities Laws 05/13/2016
2 Opinion and Order 12/29/2016
3 Notice of Appeal 01/27/2017
4 U.S. District Court Civil Docket 03/29/2017
5 Order 03/29/2017
 
 

Cases